| scholarly article | Q13442814 |
| P2093 | author name string | Evgeny M Krupitsky | |
| Tatyana N Romanova | |||
| Tatyana Y Slavina | |||
| Alexander Y Grinenko | |||
| Andrei M Burakov | |||
| Igor V Dunaevsky | |||
| P2860 | cites work | Ketamine psychedelic therapy (KPT): a review of the results of ten years of research | Q30538308 |
| Ketamine psychotherapy for heroin addiction: immediate effects and two-year follow-up | Q34166349 | ||
| Dose-related ethanol-like effects of the NMDA antagonist, ketamine, in recently detoxified alcoholics. | Q51098151 | ||
| P433 | issue | 1 | |
| P921 | main subject | heroin dependence | Q18558272 |
| P304 | page(s) | 13-19 | |
| P577 | publication date | 2007-03-01 | |
| P1433 | published in | Journal of Psychoactive Drugs | Q6295808 |
| P1476 | title | Single versus repeated sessions of ketamine-assisted psychotherapy for people with heroin dependence | |
| P478 | volume | 39 |
| Q34464501 | "Word of mouse": indigenous harm reduction and online consumerism of the synthetic compound methoxphenidine |
| Q46847604 | A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment |
| Q26746137 | Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years |
| Q34535259 | Clinical applications of hallucinogens: A review |
| Q57174889 | Efficacy of Ketamine in the Treatment of Substance Use Disorders: A Systematic Review |
| Q38082838 | From "Special K" to "Special M": the evolution of the recreational use of ketamine and methoxetamine |
| Q55059681 | Hallucinogen use and intimate partner violence: Prospective evidence consistent with protective effects among men with histories of problematic substance use. |
| Q44539047 | Hallucinogen use predicts reduced recidivism among substance-involved offenders under community corrections supervision |
| Q38837851 | Ketamine for Treatment of Suicidal Ideation and Reduction of Risk for Suicidal Behavior |
| Q61875279 | Metabolism and metabolomics of ketamine: a toxicological approach |
| Q38351502 | Peak experiences and the afterglow phenomenon: when and how do therapeutic effects of hallucinogens depend on psychedelic experiences? |
| Q35084340 | Pharmacological enhancement of naltrexone treatment for opioid dependence: a review |
| Q57309250 | Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development |
| Q93048063 | Repurposing Potential of Ketamine: Opportunities and Challenges |
| Q90318457 | Reviewing the Potential of Psychedelics for the Treatment of PTSD |
| Q26779981 | Role of ketamine in acute postoperative pain management: a narrative review |
| Q47769685 | Self-experimentations with psychedelics among mental health professionals: LSD in the former Czechoslovakia |
| Q34640595 | Shaping the renaissance of psychedelic research |
| Q34018674 | The emerging role of meditation in addressing psychiatric illness, with a focus on substance use disorders |
| Q38023813 | Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses |
| Q24634006 | To use or not to use: an update on licit and illicit ketamine use |
Search more.